SCHEMBL9511353

SCHEMBL9511353

CCCCCCC[C@H]1CC[C@H](c2ccc(C#Cc3ccc(OCC)cc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACACB O00763 6/20 0.42
SPHK1 Q9NYA1 3/20 0.40
RAB9A P51151 1/20 0.40
CYP2C9 P11712 2/20 0.39
S1PR3 Q99500 1/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510162 0.99 ACACB (0.43) ACACBSPHK1RAB9ACYP2C9MAPT
SCHEMBL9512273 0.95 ACACB (0.44) ACACBRAB9ACYP2C9MAPTALDH1A1
SCHEMBL26347314 0.95 ACACB (0.44) ACACBRAB9ACYP2C9MAPTALDH1A1
SCHEMBL9511338 0.94 RAB9A (0.46) ACACBSPHK1RAB9ACYP2C9S1PR3
SCHEMBL9508812 0.92 RAB9A (0.45) ACACBSPHK1RAB9ACYP2C9S1PR3
SCHEMBL9512219 0.92 RAB9A (0.47) ACACBRAB9ACYP2C9S1PR3LMNA
SCHEMBL9743341 0.92 ACACB (0.38) ACACBSPHK1RAB9ACYP2C9S1PR3
SCHEMBL9743332 0.92 ACACB (0.38) ACACBSPHK1RAB9ACYP2C9S1PR3
SCHEMBL9744888 0.92 ACACB (0.38) ACACBSPHK1RAB9ACYP2C9S1PR3
SCHEMBL9747187 0.92 ACACB (0.38) ACACBSPHK1RAB9ACYP2C9S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed